Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhichan Granule is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai Hospital of Traditional Chinese Medicine, primarily indicated for the treatment of Parkinson's disease (PD). The preparation is intended to address both motor symptoms and non-motor complications, such as constipation, by modulating the gut microbiota and metabolic profiles. Research suggests that the granule may exert neuroprotective effects and improve gastrointestinal function through the gut-brain axis. It is typically administered as an oral granule formulation and is often used as an adjunctive therapy to standard levodopa treatment to improve clinical outcomes and reduce complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhichan Granule.